Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

T-Ray Science Inc.

Mar 2011
In Vancouver, British Columbia, Canada, T-Ray Science Inc. has announced milestones toward the commercialization of its detection technology for skin cancer. The medical device company has signed a research agreement with the Skin Care Centre at Vancouver General Hospital and the University of British Columbia, received a Health Canada ruling that will simplify the approval process for the Verisante Aura multimodality imaging and spectroscopy system for skin cancer detection, and signed a lease for a manufacturing facility in Richmond, British Columbia. The announcements indicate progress toward bringing to market the benefits of the Aura system, which include better patient outcomes, system-wide cost savings and immediate diagnoses.

BiophotonicsBusinessCanadacommercializationdetectiondiagnosticsHealth CanadaimagingindustrialmanufacturingRapidScanskin cancerspectroscopyT-Ray ScienceUniversity of British ColumbiaVancouver General HospitalVerisante Aura

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!